Loading company…
Riskpilot
← Back to search
Sign in
Get full access
TELEMARK NEVROSENTER AS
AS
Active
Org 927726955
Infanterivegen 16, 3734 Skien
Medical specialists activities · NACE 8622
Est. 2021
2 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 9,3M
+8% vs 2023
EBITDA margin
53.6%
+6% vs 2023
Equity ratio
40.8%
Financial strength
Net profit 2024
NOK 3,6M
+8% vs 2023
EBITDA — year on year
NOK millions
6M
5M
3M
2M
0M
0M
2021
3M
+300%
2022
5M
+67%
2023
5M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 9,3M
+8%
EBITDA
NOK 5M
+6%
Net profit
NOK 3,6M
+8%
Total assets
NOK 6,6M
+30%
Equity
NOK 2,7M
+95%
Employees
2
—
Company information
Legal name
TELEMARK NEVROSENTER AS
Org number
927726955
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
15. september 2021
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Legevirksomhet, eie aksjer i andre selskaper samt finasiering og annen økonomisk virksomhet som står i forbindelse med dette.
Contact
Address
Infanterivegen 16, 3734 Skien
Phone
+4735500010
Email
post@telemarknevrosenter.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Skien
All Norway companies
Revenue
NOK millions
0M
3M
5M
8M
10M
0M
2021
7M
2022
9M
2023
9M
2024
EBITDA
NOK millions
0M
1M
3M
4M
6M
0M
2021
3M
2022
5M
2023
5M
2024
Income statement
NOK thousands
Item
2021
2022
2023
2024
Revenue
123
6 535
8 639
9 325
Staff expenses
−0
−2 394
−2 664
−2 857
EBITDA
72
2 853
4 734
4 998
Depreciation & amort.
−27
−357
−411
−435
EBIT
45
2 497
4 322
4 563
Net financials
−22
−87
−27
65
Profit before tax
23
2 410
4 295
4 628
Tax
5
531
945
1 023
Net profit
18
1 879
3 350
3 605
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
Total assets
3 336
3 909
5 075
6 573
Equity
48
227
1 377
2 683
Long-term debt
3 223
1 060
34
0
Short-term debt
66
2 622
3 664
3 890
Total debt
3 289
3 682
3 697
3 890
Financial ratios
5-year trend
EBITDA margin
53.6%
This company
15.8%
Market median
+239% vs market
2021
2024
Equity ratio
40.8%
This company
38.2%
Market median
+7% vs market
2021
2024
Return on equity
134.4%
This company
18.4%
Market median
+630% vs market
2021
2024
Net profit margin
38.7%
This company
8.1%
Market median
+378% vs market
2021
2024
Asset turnover
1.42×
This company
1.12×
Market median
+27% vs market
2021
2024
Debt / equity
1.45×
This company
0.62×
Market median
-134% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-11-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
HT
Håkon Tobro
Chief Executive Officer
Chief Executive Officer
2021
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
TELEMARK NEVROSENTER AS
(this company)
GRENLAND SPESIALISTSENTER AS
Board network connections
Board members of TELEMARK NEVROSENTER AS also hold positions in
0
other companies.
Person
Role here
Other companies
Håkon Tobro
Chief Executive Officer
0 companies